Shkreli, 32, currently is CEO of Turing Pharmaceuticals. "In January 2015, the Company received a subpoena relating to a criminal investigation by the U.S. Attorney for the Eastern District of New York. The subpoena requests information regarding, among other things, the Companys relationship with the MS MB Entities and Mr.
invite response
http://www.huffingtonpost.com/entry/martin-shkreli-sec-investigation_5601a3c4e4b08820d91a6b6f